在体单向肠灌流模型研究白芷中三种成分的吸收特性

目的:研究白芷中有效成分欧前胡素、异欧前胡素和花椒毒酚在大鼠小肠各段的吸收特征。方法:采用大鼠在体单向肠灌流模型结合HPLC法同时测定肠灌流液中欧前胡素、异欧前胡素和花椒毒酚含量的变化,考察高、中、低三组剂量下三种成分在十二指肠、空肠和回肠的吸收特性。结果:三种成分随着剂量的增大,吸收速率常数(Ka)和有效渗透系数(Peff)逐渐增大。三种成分相同剂量下各肠段间吸收均无显著性差异,其吸收大小顺序为:欧前胡素异欧前胡素花椒毒酚。结论:白芷三种主要成分在各肠段均吸收良好,吸收大小呈剂量相关性。     

腹腔镜手术治疗粘连性肠梗阻的疗效及安全性研究

目的：探讨腹腔镜粘连松解术治疗粘连性肠梗阻（AIO）的疗效，减少再梗阻率。方法：将120 例AIO 患者随机分为两组，每 组60 例，开腹组实施开腹手术，腹腔镜组实施腹腔镜粘连松解术，观察两组术后恢复及并发症发生情况，对再梗阻危险因素进行 Logistic 回归分析。结果：腹腔镜组术中失血量（73.48± 9.32）mL，少于开腹组的（207.45± 33.21）mL（P<0.05）；腹腔镜组手术、术后 镇痛、下床活动、肠恢复蠕动、肛门恢复排气、拔除尿管及住院时间分别为（69.15± 10.13）min、（14.67± 7.23）h、（27.14± 7.04）h、 （3.11± 0.96）d、（3.24± 1.02）d、（3.37± 1.23）d、（7.95± 3.05）d，均短于开腹组的（83.84± 9.24）min、（27.38± 8.02）h、（36.23± 5.87） h、（4.05± 1.35）d、（4.35± 1.74）d、（5.02± 2.13）d、（10.35± 3.71）d（P<0.05)；腹腔镜组并发症发生率、再梗阻率分别为10.00%、 10.00%，均低于开腹组的33.33%、40.00%（P<0.05)；多因素Logistic 回归分析显示开腹手术、手术时间≥ 60 min 是再梗阻发生的独 立危险因素。结论：腹腔镜手术治疗AIO 疗效优于开腹手术，而且并发症与再梗阻率低。     

灵芝孢子粉对重症急性胰腺炎大鼠肠道微生态失调的调整作用

目的探讨灵芝孢子粉对重症急性胰腺炎（SAP）导致的肠道微生态失调的调整作用。方法采用胆胰管逆行注射5％牛磺胆酸钠法造成SAP模型；SD大鼠随机分为假手术组、模型组、奥曲肽治疗组、灵芝孢子粉治疗组及灵芝孢子粉奥曲肽联合治疗组；于给药7d后处死大鼠，进行肠道菌群、肝脏及胰腺细菌易位检测。结果SAP时出现明显的肠道菌群紊乱，细菌易位。经治疗后发现，灵芝孢子粉能够扶植双歧杆菌、乳酸杆菌的生长，使肠杆菌的数量减少，并可控制细菌易位。将灵芝孢子粉与奥曲肽合用作用更佳，与其他治疗组相比差异有显著性（P〈0．05）。结论灵芝孢子粉可调整SAP时出现的肠道微生态失调，其与奥曲肽联合应用治疗SAP可降低感染率，取得较好的疗效。     

双歧杆菌对新生大鼠坏死性小肠结肠炎肠损伤及肠道菌群影响

目的建立新生SD大鼠坏死性小肠结肠炎（NEC）模型，探讨添加双歧杆菌对新生大鼠NEC模型肠损伤的保护作用及肠道菌群的影响，为应用双歧杆菌防治NEC提供依据：方法SD新生大鼠出生48h开始给予鼠配方奶人工喂养，100％氮气缺氧90s，4℃冷刺激10min，每天2次，连续3d，建立新生SD大鼠NEC模型。按析因设计，32只新生SD大鼠随机分成4组，每组动物各8只。A组为NEC模型组并在出生48h起每日给予长双歧杆菌灌胃（1×10^8CFU／d）；B组为NEC模型组，C组为对照组，都未添加双歧杆菌；D组为对照组并给予长双歧杆菌灌胃（1×10^8CFU／d）。在最后一次缺氧、冷刺激后24h空腹断头处死大鼠，留取回盲部近端肠管组织进行肠组织损伤评分，组织学评分≥2确定为NEC；实验前后留取各组新生鼠粪便，按照张秀荣方法进行肠道菌群检测。应用Kruskal-Wallis H检验等方法进行统计学分析，α=0．05为显著性检验标准。结果开始造模后，A、B组新生SD大鼠相继出现腹泻、腹胀、萎靡、活动减少，A组程度较轻。A、B、C和D组肠组织损伤评分（^-x±s）分别为1．88±0.84、3．13±0．84、0．63±0．52、0．50±0.54，各组间肠组织损伤评分差异有显著性，与B组相比，A组肠组织损伤评分明显降低，但仍高于C、D两组，差异均有显著性。各组实验前肠道细菌总数，杆菌、球菌数，G^＋杆菌、G^＋球菌数差异均无显著性，肠道菌群中杆球菌比值在正常范围中。实验结束时，各组间新生鼠肠道细菌总数，杆菌、球菌数，杆球菌比值，G^＋杆菌、G^＋球菌数及其占肠道总菌群数的比率差异均有显著性；除B组杆菌数外，与实验前相比，各组新生大鼠实验结束后肠道细菌总数、球菌数、杆菌数、G^＋杆菌数、G^＋球菌数均有显著增加，差异均有显著性；A、B组肠道杆球菌比值和G^＋杆菌数占肠道总菌群数比     

Character of interactions of saprophytic soil microflora via gaseous metabolites

The character of interaction between saprophytic soil bacteria via gaseous metabolites was studied. It was established that, at the metabolic level, a diverse character of interspecies interrelationships between bacteria exist, directly influencing their reproduction and preservation in soil. Volatile compounds produced by bacteria are able to act as both intra-and interspecies regulators of microbial communities. The soil microbiocenosis composition may be therefore regulated by volatile products of metabolism of saprophytic soil bacteria. Methanol released by bacteria into the environment plays an important role in this process.     

调整肠道菌群对肝癌介入治疗后肝功能及内毒素的影响作用研究

目的了解调整肠道菌群在肝癌介入治疗中的作用。方法将56例肝癌患者随机分为2组,治疗组在肝动脉化疗栓塞（TACE）前后常规治疗加服培菲康,对照组TACE前后按常规治疗,2组TACE前后检测转氨酶和内毒素水平。结果治疗组血肝功能水平与术前相比差异有显著性（P〈0.05）,而对照组血肝功能水平比术前明显降低（P〈0.01）;治疗组血内毒素水平与术前相比差异无显著性（P〉0.05）,而对照组血内毒素水平比术前升高（P〈0.05）;治疗组在TACE后血转氨酶和内毒素水平较对照组均降低（P〈0.05）。结论肝癌TACE后应用微生态制剂,可降低血内毒素水平,改善肝功能状态,对于减少并发症,促进机体的恢复有重要意义。     

基于“心与小肠相表里”理论探讨肠道微生态与骨质疏松症的关系

近年来相关研究显示,肠道微生态在骨质疏松症的发生发展中起着重要作用。中医脏腑理论密切关注脏腑之间的生理病理关系,以中医经典《内经》“心与小肠相表里”理论为基础,探讨心、小肠、肠道微生态与骨质疏松症之间的关系。研究发现肠道微生态可能是心系疾病导致骨质疏松症的途径之一,这一发现可能为骨质疏松症的研究与防治提供一定的理论依据。     

Íleo biliar como causa de dolor abdominal en el paciente anciano

Gallstone ileus is a rare and potentially serious complication of cholelithiasis. It is defined as a mechanical intestinal obstruction secondary to the presence of a gallstone in the intestinal luz. The most frequent cause is impaction of the calculus in the ileum after passing through a bilioenteric fístula. It has a high morbidity and mortality rate, mainly due to the difficulty and delay in its diagnosis. A retrospective study is presented of 4 cases of gallstone ileus treated between 2013 and 2017 in the Hospital Nuestra Señora del Prado. An analysis was performed on the clinical characteristics, diagnostic tests, and surgical treatment.     

不同海拔高原低压缺氧环境下大鼠肠道病理损伤特点

目的:探讨不同海拔高度的高原低压缺氧环境下大鼠肠道病理损伤的特点。方法:将30只SD雄性大鼠随机分5组:平原对照组、5000米海拔高度10天组、5000米海拔高度21天组、6500米海拔高度10天组、6500米海拔高度21天组,每组6只。大鼠在平原环境或模拟高原环境中常规饲养,在相应时间点,深度麻醉受试大鼠致死,取材,固定、HE染色后镜检并进行病理学损伤评分。结果:各高原组空、回肠病理损伤评分均显著高于平原对照组(P0.01),5000 m暴露21d组空肠、回肠、结肠病理损伤评分显著高于5000 m暴露10 d组,明显低于6500 m暴露21d组,6500 m暴露10d组空肠、回肠、结肠病理损伤评分显著高于5000 m暴露10 d组(P0.01或P0.05)。5000 m暴露10 d组结肠损伤病理评分与平原对照组比较差异无统计学意义外,其余高原组结肠病理损伤评分均显著高于平原对照组(P0.01或P0.05)。5000 m暴露21 d组空肠与结肠病理损伤评分存在显著性差异(P0.05);6500 m暴露21 d组空肠和回结肠均与结肠病理损伤评分存在显著性差异(P0.05,P0.01)。结论:肠道粘膜随着海拔高度和缺氧时间的延长而损伤加重。在相同的情况下,小肠的损伤较结肠严重,但空肠和回肠的损伤无明显差异,结肠损伤的发生较晚且与高原环境停留时间具有明显关系,提示在进入高原早期应将小肠病理损伤的防治作为重点。     

Influence of different prebiotics and mode of their administration on broiler chicken performance

In the post-antibiotics era, prebiotics are proposed as alternatives to antibiotic growth promoters in poultry production. The goal of this study was to compare in ovo method of prebiotic delivery with in-water supplementation and with both methods combined (in ovo+in-water) in broiler chickens. Two trials were conducted. Trial 1 was carried out to optimize the doses of two prebiotics, DN (DiNovo®, extract of beta-glucans) and BI (Bi²tos, trans-galactooligosaccharides), for in ovo delivery. The estimated parameters were hatchability and bacteriological status of the newly hatched chicks. Prebiotics were dissolved in 0.2 ml of physiological saline, at the doses: 0.18, 0.88, 3.5 and 7.0 mg/embryo; control group (C) was injected in ovo with 0.2 ml of physiological saline. Trial 2 was conducted to evaluate effects of different prebiotics (DN, BI and raffinose family oligosaccharides (RFO)) delivered in ovo, in-water and in a combined way (in ovo+in-water) on broiler chickens performance. The results of the Trial 1 indicated that the optimal dose of DN and BI prebiotics delivered in ovo, that did not reduce chicks’ hatchability, was 0.88 mg/embryo (DN) and 3.5 mg/embryo (BI). Both prebiotics numerically increased number of lactobacilli and bifidobacteria in chicken feces (P>0.05). In Trial 2, all prebiotics (DN, BI and RFO) significantly increased BW gain compared with the C group (P<0.05), especially during the first 21 days of life. However, feed intake and feed conversion ratio were increased upon prebiotics delivery irrespective of method used. Injection of prebiotics in ovo combined with in-water supplementation did not express synergistic effects on broilers performance compared with in ovo injection only. Taken together, those results confirm that single in ovo prebiotics injection into the chicken embryo can successfully replace prolonged in-water supplementation post hatching.